PUBLISHER: TechSci Research | PRODUCT CODE: 1063911
PUBLISHER: TechSci Research | PRODUCT CODE: 1063911
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.
The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.
The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.
Major companies operating in the global gynecology market are: Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.
TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.
In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: